What You Should Know: - COTA, Inc., an oncology real-world data and analytics company and the University of Chicago Medicine announced a research collaboration agreement to investigate racial disparities of care in multiple myeloma to better understand differences in the diagnosis, treatment patterns, and outcomes of patients with this type of cancer. - Multiple myeloma is the second-most-common hematologic malignancy, with an estimated 34,920 new cases and 12,410 deaths expected to occur
Read More
Cancer | Digital Health Impact on Cancer Care | Policy, News, Analysis, Insights - HIT Consultant
Medable, Aural Analytics Partner to Develop Remote Cancer Digital Solutions
What You Should Know: - Medable announced today that it is now partnering with Aural Analytics to test and develop remote digital data tools and harmonization methods designed to assess the wellbeing of patients undergoing cancer treatment. - The addition of Aural Analytics’ speech biomarkers application improves outcomes data with important speech and language-based information about motor, cognitive, and respiratory function furthering the scope of digital measures which can be captured
Read More
Redesign Health Spinout Jasper Health Launches AI-Driven Cancer Care Platform
What You Should Know: - Jasper Health launched today as the first end-to-end care experience that navigates, connects, and provides actionable insights throughout the cancer journey for individuals with cancer, their caregivers, and providers. - Jasper combines an easy-to-navigate user interface with leading oncology support to help guide Jasper Members and caregivers through the myriad of challenges that arise post-diagnosis. United by a team of digital health experts, specialized
Read More
Cancer Centers: Here’s How We Can Restart Clinical Trials Today
Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More
Outcomes4Me Raises $12M for AI-Powered Cancer Patient Empowerment Platform
What You Should Know: - Outcomes4Me Inc., a Cambridge, MA-based developer of an Artificial Intelligence (AI)-powered platform to empower cancer patients to navigate their care, today announced it has raised $12 million in an oversubscribed Series A round led by Northpond Ventures, with participation from all existing investors, including Sierra Ventures, Asset Management Ventures, Merstal Ltd, IRA Capital, and others. Andrea Jackson, a Northpond Ventures Director, will
Read More
Adventist Health, OSF HealthCare Use CancerIQ to Prioritize Patients for Preventive Cancer Screenings
What You Should Know: - As the nation braces for a rise in advanced stage cancer diagnoses due to the COVID-19 pandemic, two leading health systems – Adventist Health and OSF HealthCare – are using CancerIQ’s precision prevention platform and telehealth to equitably prioritize high-risk patients for screening and identify cancer in its earliest stages. - Clinicians to present at National Consortium of Breast Center conference on
Read More
C2i Genomics Raises $100M for Whole-Genome Cancer Treatment Intelligence Platform
- Cancer intelligence company, C2i Genomics announced it has raised $100M in financing from Casdin Capital, NFX, Duquesne Family Office, Section 32, iGlobe Partners, Driehaus Capital and others. - Funds will be used to accelerate clinical development and commercialization of the company’s C2-Intelligence Platform, a cancer diagnostics service, that uses AI pattern recognition and whole-genome analysis to provide rapid and cancer-specific detection of residual disease 100x more sensitive than
Read More
American Cancer Society, Roundtrip Partner to Enable Transportation for Cancer Patients
What You Should Know: - Healthcare tech & ridesharing company Roundtrip has rolled out its platform with the American Cancer Society (ACS), specifically its 'Road to Recovery' program in order to enable cancer patients to connect to the treatment they need. The goal is to reduce the overall cancer mortality rate by 40% by 2035. - Together, Roundtrip and ACS will work to ease the stressful process of transportation coordination and allow patients to focus
Read More
Philips, Ibex Medical Analytics Partner on AI-Powered Digital Pathology Adoption
What You Should Know: - Philips and Ibex Medical Analytics announced a strategic partnership to globally commercialize clinically proven, AI-powered digital pathology solutions. The collaboration further cements Philips’ commitment to integrated diagnostics providing a clear path to precision diagnosis. - The trend towards centralized pathology labs, the global shortage of trained pathologists, and increasing demands on histopathology posed by the growing number of cancer
Read More
Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching
What You Should Know: - Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardinal network. VIPER will be a part of Cardinal Health’s new Navista advanced suite of technology solutions designed to help oncologists improve outcomes, provide high quality care at the best possible cost and select the right care plan at the onset of
Read More
